• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab.

作者信息

Benzaquen Michael, Monnier Jilliana, Beaussault Yasmine, Rouby Frank, Berbis Philippe

机构信息

Service de Dermatologie, Hôpital Nord and, Marseille, France.

Centre Régional de Pharmacovigilance Marseille Provence Corse, Service de Pharmacologie Clinique, Hôpital Timone, Marseille, France.

出版信息

Australas J Dermatol. 2017 Nov;58(4):e270-e271. doi: 10.1111/ajd.12545. Epub 2017 Jun 28.

DOI:10.1111/ajd.12545
PMID:28660635
Abstract
摘要

相似文献

1
Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab.在用阿达木单抗治疗银屑病期间出现的坏疽性脓皮病：优特克单抗的有效性。
Australas J Dermatol. 2017 Nov;58(4):e270-e271. doi: 10.1111/ajd.12545. Epub 2017 Jun 28.
2
Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum.从阿达木单抗转换为布罗达鲁单抗可能是坏疽性脓皮病发病的触发因素。
Australas J Dermatol. 2024 Jun;65(4):e111-e113. doi: 10.1111/ajd.14266. Epub 2024 Apr 10.
3
Pyoderma gangrenosum triggered by switching from adalimumab to secukinumab.从阿达木单抗换用司库奇尤单抗引发的坏疽性脓皮病。
J Dermatol. 2019 Mar;46(3):e108-e109. doi: 10.1111/1346-8138.14611. Epub 2018 Sep 7.
4
Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.用优特克单抗治疗重度顽固性坏疽性脓皮病。
Australas J Dermatol. 2018 May;59(2):131-134. doi: 10.1111/ajd.12744. Epub 2017 Dec 4.
5
Worsening of Psoriatic Arthritis After Ustekinumab Treatment.使用司库奇尤单抗治疗后银屑病关节炎病情恶化。
Am J Ther. 2018 May/Jun;25(3):e381-e382. doi: 10.1097/MJT.0000000000000546.
6
Paradoxical uveitis and pyoderma gangrenosum in a patient with psoriatic arthritis under infliximab treatment.一名接受英夫利昔单抗治疗的银屑病关节炎患者出现矛盾性葡萄膜炎和坏疽性脓皮病。
J Dtsch Dermatol Ges. 2018 Sep;16(9):1139-1140. doi: 10.1111/ddg.13632. Epub 2018 Aug 21.
7
Ustekinumab in a patient with pyoderma gangrenosum and refractory Crohn's disease.优特克单抗治疗坏疽性脓皮病合并难治性克罗恩病1例
Med Clin (Barc). 2019 Oct 25;153(8):e35-e36. doi: 10.1016/j.medcli.2018.12.004. Epub 2019 Feb 19.
8
Refractory Pyoderma Gangrenosum in a Patient With Crohn's Disease: Complete Response to Ustekinumab.一名克罗恩病患者的难治性坏疽性脓皮病：对优特克单抗完全缓解
J Crohns Colitis. 2019 May 27;13(6):812-813. doi: 10.1093/ecco-jcc/jjy200.
9
Pyoderma gangrenosum solved by ustekinumab therapy.乌司奴单抗治疗使坏疽性脓皮病得到缓解。
Gastroenterol Hepatol. 2021 Apr;44(4):299-300. doi: 10.1016/j.gastrohep.2020.06.027. Epub 2020 Oct 14.
10
Pyoderma Gangrenosum With Ulcerative Colitis Successfully Treated With Ustekinumab.用乌司奴单抗成功治疗的伴有溃疡性结肠炎的坏疽性脓皮病
Actas Dermosifiliogr (Engl Ed). 2019 Nov;110(9):776-778. doi: 10.1016/j.ad.2018.03.034. Epub 2019 May 28.

引用本文的文献

1
Secukinumab Treatment in Patients with Hidradenitis Suppurativa in Real-World Clinical Settings: A Multicenter Study.司库奇尤单抗在现实临床环境中治疗化脓性汗腺炎患者的多中心研究
Dermatol Pract Concept. 2025 Jan 30;15(1):4915. doi: 10.5826/dpc.1501a4915.
2
The Pathophysiology and Treatment of Pyoderma Gangrenosum-Current Options and New Perspectives.坏疽性脓皮病的发病机制和治疗：现有选择和新视角。
Int J Mol Sci. 2024 Feb 19;25(4):2440. doi: 10.3390/ijms25042440.
3
Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report.
慢性复发性多灶性骨髓炎患者抗TNF治疗后发生坏疽性脓皮病：药物反应还是疾病的皮肤表现？结合典型病例报告对该主题的批判性综述
Front Med (Lausanne). 2023 May 31;10:1197273. doi: 10.3389/fmed.2023.1197273. eCollection 2023.
4
Multifocal Pyoderma Gangrenosum with an Underlying Hemophagocytic Lymphohistiocytosis: Case Report and the Review of the Literature.伴有潜在噬血细胞性淋巴组织细胞增生症的多灶性坏疽性脓皮病：病例报告及文献复习
Dermatol Ther (Heidelb). 2021 Aug;11(4):1217-1237. doi: 10.1007/s13555-021-00571-3. Epub 2021 Jun 27.
5
Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.乌司奴单抗在非适应证皮肤科疾病中的其他用途：系统评价。
Arch Dermatol Res. 2022 Aug;314(6):503-514. doi: 10.1007/s00403-021-02262-7. Epub 2021 Jun 22.
6
Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab.司库奇尤单抗诱导的坏疽性脓皮病在一名用优特克单抗成功治疗的银屑病患者中出现。
JAAD Case Rep. 2020 Jun 16;6(8):731-733. doi: 10.1016/j.jdcr.2020.06.011. eCollection 2020 Aug.
7
Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.采用负压伤口治疗和植皮（包括异种移植物）治疗坏疽性脓皮病的手术治疗：161 例的个人经验和综合回顾。
Adv Wound Care (New Rochelle). 2020 Jul;9(7):405-425. doi: 10.1089/wound.2020.1160. Epub 2020 Apr 28.
8
Multiple Facial Lesions of Recalcitrant Pyoderma Gangrenosum Successfully Treated with Adalimumab.阿达木单抗成功治疗多发性顽固性坏疽性脓皮病面部病变
J Clin Aesthet Dermatol. 2019 May;12(5):28-32. Epub 2019 May 1.